Clinical trial
SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and…
NCT00006361 · Memorial Sloan Kettering Cancer Center, Other · Completed
Key facts
| NCT number | NCT00006361 |
|---|---|
| Title | SU5416 in Treating Patients With Advanced or Recurrent Cancer of the Head and Neck |
| Official title | A Phase II Trial of SU5416 (NSC #696819) in Patients With Advanced or Recurrent Squamous Cell Carcinoma of the Head and Neck |
| Lead sponsor | Memorial Sloan Kettering Cancer Center, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma of Unknown Primary, Head and Neck Cancer, Non-melanomatous Skin Cancer |
| Intervention type | Drug |
| Interventions | semaxanib |
| Start date | Dec 1, 2000 |
| Primary completion | Jan 1, 2003 |
| First posted | May 30, 2003 |
| Last update posted | Dec 4, 2009 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: